worldwide offices | contact | help | sitemap

 
 

 

 

 

Novartis Diagnostics Products

Products

PROCLEIX® TIGRIS® System

Overview

The PROCLEIX TIGRIS System is the only fully automated, integrated NAT testing platform for blood screening, enabling laboratories to attain optimal productivity. With TIGRIS, all the steps of nucleic acid testing are automated, from sample extraction to results reporting. The flexibility of the PROCLEIX TIGRIS System offers increased laboratory efficiency through process controls, safety, and minimal hands-on time—all in one small footprint.

 

 

Benefits

Decreased hands-on time with complete NAT automation

  • The PROCLEIX TIGRIS System is the first and only instrument to fully integrate and automate all the steps of nucleic acid testing (NAT):
    • Sample addition
    • Target capture
    • Amplification
    • Detection
    • Sample deactivation (destruction)
    • Results reporting
  • Once tube processing begins, approximately 1 minute of hands-on time is required each hour, maximizing workflow efficiency
  • Intuitive software manages all onboard system activity, minimizing operator intervention and variability
  • Full NAT automation improves ergonomics and reduces repetitive operator activities

 

A safe, cGMP environment within a small, enclosed system

  • All-in-one system easily fits into standard lab configurations
  • Contained system environment helps ensure sample and result integrity
  • Automation helps standardize assay processes and performance
  • Minimized operator-induced variability

 

Results integrity through built-in process controls

  • Barcode scanners provide positive sample ID and reagent tracking
  • Liquid-level sensors and dispensers help ensure consistent pipetting of sample and reagent volumes
  • Precision robotics help ensure system and results consistency and reliability
  • Software automatically enables proactive system maintenance

 

Flexibility in assays, screening methods, and tube formats

  • Use with the PROCLEIX® ULTRIO® and ULTRIO Plus® Assays for HIV-1, HBV, and HCV screening, as well as the PROCLEIX® West Nile Virus Assay
  • Can process individual donor tests and pooled blood at the same time
  • Multiple tube barcode formats can be used simultaneously (ISBT 128, Code 128, Codabar, Code 39)
  • All industry-standard tube sizes (from 12x75 mm to 16x100 mm) are accepted on TIGRIS

 

Simplified workflow with the ability to screen and discriminate on the same platform

  • The PROCLEIX TIGRIS System features the power to test analytes on a screening basis (compounded result) or discriminatory basis (individual result using discriminatory probe assays), all on the same platform
  • The compact PROCLEIX TIGRIS System can easily fit into any standard lab. Screen 1000 results in less than 9 hours in IDT with 2 TIGRIS, all in an area of less than 500 square feet (46.5 square meters)

Developed by Gen-Probe in collaboration with Novartis Diagnostics. Manufactured by Gen-Probe Incorporated. Distributed by Novartis Vaccines and Diagnostics, Inc.

 

About Novartis Vaccines

About Novartis Vaccines

Novartis Vaccines is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases. Novartis Vaccines is the division researching novel treatments.